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Background: Exposure to fine particulate matter (PM with diameter ≤ 2.5 μm; PM2.5) has been 
linked to type 2 diabetes mellitus, but associations with hyperglycemia in pregnancy have not been 
well studied.
Methods: We studied Boston, Massachusetts–area pregnant women without known diabetes. 
We identified impaired glucose tolerance (IGT) and gestational diabetes mellitus (GDM) during 
pregnancy from clinical glucose tolerance tests at median 28.1 weeks gestation. We used residential 
addresses to estimate second-trimester PM2.5 and black carbon exposure via a central monitoring 
site and spatiotemporal models. We estimated residential traffic density and roadway proximity as 
surrogates for exposure to traffic-related air pollution. We performed multinomial logistic regres-
sion analyses adjusted for sociodemographic covariates, and used multiple imputation to account 
for missing data.
results: Of 2,093 women, 65 (3%) had IGT and 118 (6%) had GDM. Second-trimester spatio-
temporal exposures ranged from 8.5 to 15.9 μg/m3 for PM2.5 and from 0.1 to 1.7 μg/m3 for black 
carbon. Traffic density was 0–30,860 vehicles/day × length of road (kilometers) within 100 m; 281 
(13%) women lived ≤ 200 m from a major road. The prevalence of IGT was elevated in the high-
est (vs. lowest) quartile of exposure to spatiotemporal PM2.5 [odds ratio (OR) = 2.63; 95% CI: 
1.15, 6.01] and traffic density (OR = 2.66; 95% CI: 1.24, 5.71). IGT also was positively associated 
with other exposure measures, although associations were not statistically significant. No pollutant 
exposures were positively associated with GDM.
conclusions: Greater exposure to PM2.5 and other traffic-related pollutants during pregnancy was 
associated with IGT but not GDM. Air pollution may contribute to abnormal glycemia in pregnancy.
citation: Fleisch AF, Gold DR, Rifas-Shiman SL, Koutrakis P, Schwartz JD, Kloog I, 
Melly S, Coull BA, Zanobetti A, Gillman MW, Oken E. 2014. Air pollution exposure and 
abnormal glucose tolerance during pregnancy: the Project Viva Cohort. Environ Health Perspect 
122:378–383;  http://dx.doi.org/10.1289/ehp.1307065
Introduction
Air pollution, especially fine particulate 
matter (PM2.5), which is composed of par-
ticles with an aerodynamic diameter ≤ 2.5 μm, 
may promote insulin resistance [reviewed 
by Rajagopalan and Brook (2012)]. PM2.5 
results from combustion and is a constitu-
ent of automobile exhaust and power plant 
emissions. It is composed of black (elemen-
tal) carbon, organic carbon, sulfates, nitrates, 
metals, dust, and biological material. Because 
of its small size, PM2.5 readily enters the 
bronchi and alveoli. PM2.5 has been associ-
ated with local and systemic inflammation 
and adverse cardiorespiratory outcomes. For 
example, PM2.5-exposed rodents developed 
pulmonary (Happo et al. 2012) and sys-
temic (Wang et al. 2013) inflammation and 
impaired cardiovascular function (Wang et al. 
2013). In population-based human studies, 
higher PM2.5 exposure was associated with 
increased systemic inflammation in pregnant 
women (Lee et al. 2011) and increased cardio-
respiratory hospitalizations in nonpregnant 
adults (Dominici et al. 2006).
In high-fat-diet and normal-weight rodent 
models, PM2.5 exposure induced insulin resis-
tance by promoting adipose inflammation and 
through potential disruption of insulin signal 
transduction (Sun et al. 2009; Xu et al. 2011). 
Several adult cohort studies have explored asso-
ciations between long-term particulate mat-
ter exposure and self-reported type 2 diabetes 
mellitus (Andersen et al. 2012; Brook et al. 
2008; Coogan et al. 2012; Krämer et al. 2010; 
Pearson et al. 2010; Puett et al. 2011), and all 
but one (Puett et al. 2011) reported positive 
associations between diabetes and particulate 
matter exposures.
Pregnancy is a particularly vulnerable time 
for the development of abnormal glycemia 
because insulin resistance increases as part of 
the normal physiological adaptation to ensure 
fuel transfer to the fetus. Up to 18% of preg-
nant women worldwide develop some degree 
of abnormal glucose tolerance by the end of 
the second trimester (Sacks et al. 2012). About 
one-third of these women meet current diag-
nostic criteria for gestational diabetes mellitus 
(GDM), and the remaining two-thirds have 
impaired glucose tolerance (IGT), a milder 
form of glucose intolerance (International 
Association of Diabetes Pregnancy Study 
Groups Consensus Panel et al. 2010), 
which, like GDM, is associated with adverse 
maternal (Retnakaran et al. 2008) and fetal 
(Hapo Study Cooperative Research Group 
et al. 2008) outcomes. In contrast with type 2 
diabetes, which often develops over years and 
for which diagnosis is often delayed (Inzucchi 
2012), insulin resistance in pregnancy develops 
during the second trimester, and screening 
routinely occurs at the end of this trimester 
(Butte 2000). Thus, when considering the 
effects of air pollution on glycemia, focus-
ing on insulin resistance during pregnancy 
permits evaluation of acute, directly relevant 
exposure windows.
A cohort study in the Netherlands 
(van den Hooven et al. 2009) reported no 
association between traffic density and GDM, 
whereas a study of birth registry data in 
Sweden reported a monotonic dose–response 
association between nitrogen oxides (NOx) 
and GDM and positive associations with traf-
fic density (Malmqvist et al. 2013). However, 
neither study measured PM2.5 or black carbon 
exposure, neither assessed more mild degrees 
of GDM, and the Swedish cohort did not 
include individual-level socioeconomic status 
covariate data.
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The primary objective of the present analy-
sis was to evaluate the association of second-
trimester PM2.5 exposure, using two exposure 
assessment approaches, with glycemia in a 
large cohort of pregnant women residing in 
the greater Boston, Massachusetts, area. We 
hypothesized that PM2.5 exposure would be 
positively associated with IGT and GDM. 
Secondary objectives were to estimate associa-
tions with additional measures of exposure to 
traffic-related air pollution, including black 
carbon concentration, neighborhood traffic 
density, and home roadway proximity.
Methods
Study population and design. From 1999 to 
2002, we recruited Boston-area women at 
their first prenatal visit to Harvard Vanguard 
Medical Associates, a multi-  specialty group 
practice with eight urban and subur-
ban obstetric offices throughout eastern 
Massachusetts, to participate in the Project 
Viva cohort. Eligibility criteria for Project 
Viva included fluency in English, gestational 
age of ≤ 22 weeks at enrollment, and single-
ton pregnancy. A total of 2,128 women with 
a live birth were included in Project Viva; for 
the present analysis, we excluded 16 women 
with preexisting type 1 or type 2 diabetes 
mellitus and 19 women without any exposure 
measurements available. Of the remaining 
2,093, the number included in each analy-
sis varied from 1,584 to 2,092 based on the 
availability of exposure data (Table 1).
Participants provided their residential 
address at enrollment and updated it at the 
second study visit, timed to coincide with clini-
cal glycemic screening (median, 28.1 weeks). 
We estimated exposures for all women who 
lived at an address in our catchment area for at 
least 75% of the second trimester. Geocoding 
and spatial analyses were done using ArcGIS 
version 10.1 and StreetMapTM roads (ESRI, 
Redlands, CA, USA).
All participants provided written informed 
consent, and institutional review boards of the 
participating sites approved the study.
Air pollution exposure assessments. We 
measured daily PM2.5 and black carbon at 
a monitoring site located atop the Harvard 
University Countway Library in Boston, 
Massachusetts (Kang et al. 2010). We assigned 
these daily central site values to women living 
within 40 km of the monitor.
We also estimated PM2.5 and black car-
bon concentrations at each woman’s resi-
dential address using spatiotemporal models. 
Although estimated, these concentrations had 
the advantage of more closely matching a wom-
an’s residential address than did   central-site 
measurements. Also, spatiotemporal models 
allowed for spatial as well as temporal variability 
(i.e., two women pregnant at a similar time 
but living in different neighborhoods could 
have different exposures). For estimates of daily 
spatiotemporal PM2.5 exposure (Kloog et al. 
2011), we used mixed-effects models with ran-
dom slopes for day and nested regions to cali-
brate daily satellite aerosol optical depth (AOD) 
data (http://ladsweb.nascom.nasa.gov/index.
html) at a resolution of a 10 × 10 km spatial 
grid (2000–2008) with all monitored PM2.5 
measurements in New England. We then used 
a generalized additive mixed model with spa-
tial smoothing and regional measured PM2.5, 
AOD values in neighboring cells, and land use 
variables to estimate PM2.5 for location-day 
pairs with missing AOD. The “out of sample” 
10-fold cross-validation R2 for days with and 
without available AOD data was 0.83 and 0.81, 
respectively.
We estimated daily spatiotemporal black 
carbon exposure at each residential address 
using a validated spatiotemporal land use 
regression model (Gryparis et al. 2007) that 
included daily average black carbon esti-
mates from 148 monitoring stations from 
January 1999 to August 2011. Predictors in 
the final model included address-specific land 
use, 2009 traffic density, daily meteorologi-
cal factors, other seasonal characteristics, and 
their interactions. We also used data from 
the Boston central monitoring site to reflect 
daily variations in black carbon in the region. 
For each of the pollutants, we estimated 
second-trimester exposures by averaging daily 
concentrations from day 94 through day 187 
after last menstrual period.
We estimated neighborhood traffic density 
[average daily traffic (vehicles/day) × length 
of road (kilometers) within 100 m] using the 
2002 road inventory from the Massachusetts 
Executive Office of Transportation [as in 
Kloog et al. (2012); Zeka et al. (2008)]. Home 
roadway proximity (distance to census fea-
ture class code A1 or A2 roads) was calculated 
using U.S. and Canada detailed streets from 
Street MapTM North America ArcGIS 10 
Data and Maps (time period of content 2005; 
ArcGIS). For both variables we used resi-
dential address at study enrollment (median, 
9.9 weeks gestation).
Glycemic screening and classification 
of glucose tolerance status. At the end of 
the second trimester of gestation (median, 
28.1 weeks), participating women completed 
routine clinical screening for GDM (Herring 
et al. 2009). If serum glucose 1 hr after a non-
fasting 50 g oral glucose challenge test (GCT) 
was ≥ 140 mg/dL, the participant was referred 
for a 3-hr fasting 100-g oral glucose tolerance 
test (OGTT). Normal OGTT results, per 
American Diabetes Association (ADA) cri-
teria (American Diabetes Association 2008), 
were blood glucose ≤ 95 mg/dL at baseline, 
≤ 180 mg/dL at 1 hr, ≤ 155 mg/dL at 2 hr, 
and ≤ 140 mg/dL at 3 hr. Given a combi-
nation of the GCT and OGTT results, we 
focused on two categories of glucose intoler-
ance: a) We defined GDM as failing the GCT 
with ≥ 2 high values on the OGTT as per 
ADA criteria (American Diabetes Association 
2008); and b) we defined IGT as failing the 
GCT (1-hr glucose result of ≥ 140 mg/dL) 
with one high value on the OGTT. Although 
there is not currently a uniformly recognized 
definition for IGT during pregnancy, this 
definition allowed for comparison with previ-
ously published work (Herring et al. 2009; 
Retnakaran et al. 2008; Saldana et al. 2006). 
The reference group [normal glucose toler-
ance (NGT)] comprised women with GCT 
results ≤ 140 mg/dL who did not have OGTT 
testing. We classified the remaining mothers 
who had GCT results ≥ 140 mg/dL but no 
high values on the OGTT as a separate out-
come group because data are mixed regard-
ing whether maternal and fetal outcomes for 
women with these laboratory results are dif-
ferent from women with NGT (Hillier et al. 
2007; Retnakaran et al. 2008).
Assessment of covariates. Using a combina-
tion of interviews and questionnaires, we col-
lected information on participants’ age, race/
ethnicity, education, household income, his-
tory of GDM in a previous pregnancy, family 
history of diabetes mellitus, smoking habits, 
and date of the last menstrual period updated 
with ultrasound. We calculated prepregnancy 
body mass index (BMI; kilograms per meter 
squared) from self-reported height and weight. 
We calculated total gestational weight gain 
up to glycemic screening as the difference 
between the weight measured on the date of 
the glycemic screen and self-reported pre-
pregnancy weight (Herring et al. 2009).
Statistical analysis. We used multi-
nomial logistic regression analyses to evaluate 
Table 1. Of 2,093 women eligible to be included in the analyses, sample sizes for each analysis varied 
based on the exposure method.
Exposure Sample size Inclusion criteria
Central-site PM2.5 1,943 Residential address within 40 km of the central monitoring site
Spatiotemporal PM2.5 1,584 Second trimester began after March 2000 (at which time satellite 
data became available)
Central-site black carbon 1,943 Residential address within 40 km of the central monitoring site
Spatiotemporal black carbon 2,069 Residential address within our spatiotemporal black carbon model 
area, which included eastern Massachusetts
Neighborhood traffic density 2,081 Residential address in Massachusetts mainland
Home roadway proximity 2,092 Residential address able to be geocodedFleisch et al.
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associations of air pollution exposures with 
IGT and GDM. In each model, we esti-
mated separate ORs for 4 possible outcomes: 
a) NGT, which we used as a common “ref-
erence” outcome; b) failed GCT normal 
OGTT; c) IGT; and d) GDM. We estimated 
separate odds ratios (ORs) for these outcomes 
because other studies have shown different 
predictors for IGT versus GDM (Hillier et al. 
2007; Saldana et al. 2006).
We considered each of the exposures (cen-
tral-site PM2.5, spatiotemporal PM2.5, central-
site black carbon, spatiotemporal black carbon, 
traffic density, and distance to roadway) in 
separate models. We initially modeled PM2.5, 
black carbon, and traffic density exposures as 
categorical variables (in quartiles) to assess for 
potential nonlinearity of exposure–  outcome 
relationships. We a priori dichotomized 
proximity to major roadway as > or ≤ 200 m 
for consistency with previous studies, using 
> 200 m as a reference group (Puett et al. 
2011; van den Hooven et al. 2009). We first 
fit unadjusted models. Next we created a full 
multivariate model for each of the exposures 
that included as covariates maternal age (con-
tinuous), prepregnancy BMI (continuous), 
pregnancy weight gain through time of OGTT 
(continuous), race/ethnicity (white, black, 
Asian, Hispanic, other), education (with or 
without college degree), smoking habits (never, 
former, or during pregnancy), season of last 
menstrual period (4 seasons), prior GDM (yes, 
no, or nulliparous), family history of diabetes 
(yes or no), and household income (> $70,000 
or ≤ $70,000). We then excluded household 
income and smoking habits because neither 
was a confounder of the relationship of any 
of the exposures with IGT or GDM (i.e., the 
estimate for the primary exposure changed 
by < 10%). Because categorical exposure– 
outcome relationships appeared linear, we also 
modeled PM2.5, black carbon, and traffic den-
sity exposures as continuous measures, and 
expressed associations per interquartile range 
(IQR) increase in exposure.
As is common in large epidemiologic 
analyses, many participants were missing data 
on one or more variables. We used chained 
equations to multiply impute missing values 
(White et al. 2011) [the MI procedure in 
SAS (SAS Institute Inc., Cary, NC, USA)]. 
We generated 50 imputed data sets, and all 
model results were generated by appropri-
ately combining these results (Rubin 2004). 
To avoid incorrect imputations, we used all 
2,128 cohort participants with live births and 
included all covariates as well as exposure and 
outcome variables in the imputation process 
(White et al. 2011). In the analytic data set, 
we included only participants with measured 
exposures (n = 2,093). In women missing out-
come data (n = 43), we imputed outcomes 
in addition to covariates. Including imputed 
outcome data could add additional covariate 
information and would not be expected to bias 
regression results because exposure data were 
not imputed and outcomes were assumed to be 
missing at   random (Little 1992).
We performed several sensitivity analyses. 
We individually included additional covari-
ates for trends over time (based on the cal-
endar date of the last menstrual period), 
pre  pregnancy BMI squared, and 1999 census 
tract median household income (based on res-
idential address at enrollment) (U.S. Census 
Bureau 2000a) to the final model. We also 
limited the analysis to the subset of women 
with no history of prior GDM (n = 2,051) 
and the subset of women with a measured 
rather than imputed outcome (n = 2,050). 
Because spatiotemporal PM2.5 and traffic den-
sity were both significantly associated with 
IGT and were not highly collinear, we consid-
ered both exposures concomitantly in the final 
model. All analyses were conducted using SAS 
version 9.3 (SAS Institute Inc.).
Results
Of the 2,093 women in the study popula-
tion, 65 (3%) had IGT and 118 (6%) had 
GDM. Second-trimester mean ± SD (range) 
central-site PM2.5 was 10.9 ± 1.4 μg/m3 
(8.3–17.2 μg/m3) and spatiotemporal PM2.5 
was 11.9 ± 1.4 μg/m3 (8.5–15.9 μg/m3). 
Thus, we anticipated that PM2.5 annual aver-
ages in the study population were generally 
lower than the U.S. Environmental Protection 
Agency (2013) threshold for annual exposure, 
which was 15 μg/m3 at the time and was low-
ered to 12 μg/m3 in December 2012. Second-
trimester mean ± SD (range) central-site black 
carbon was 0.9 ± 0.1 μg/m3 (0.6–1.1 μg/m3) 
and spatio  temporal black carbon was 
0.7 ± 0.2 μg/m3 (0.1–1.7 μg/m3). Traffic 
density mean was 1,621 ± 2,234 (0–30,860) 
vehicles/day × km of road within 100 m; 272 
(13%) of the women lived within 200 m of a 
major roadway. Central-site PM2.5 and black 
carbon were not correlated with traffic den-
sity or roadway proximity, and other expo-
sures were moderately correlated (Spearman 
correlation coefficients 0.08–0.79) (see 
Supplemental Material, Table S1). Mean age 
at enrollment was 31.8 years, and mean pre-
pregnancy BMI was 24.9 kg/m2 (Table 2). 
Only a small percentage of women had a fam-
ily history of diabetes (8%) or prior GDM 
(2%). Imputation had little or no influence 
on the distribution of participant charac  teris-
tics (see Supplemental Material, Table S2). 
Women recruited before March 2000, when 
satellite measurements became available, and 
who therefore were not included in analyses 
of spatiotemporal PM2.5, had lower central-
site PM2.5 exposure and higher black carbon 
exposure but did not differ from other partici-
pants in terms of sociodemographic charac-
teristics or the proportions of women with 
IGT or GDM (see Supplemental Material, 
Table S2). Of the covariates, only race/ 
ethnicity varied by exposure status, with white 
Table 2. Characteristics of participants in Project Viva [mean ± SD or n (%)], overalla and by spatio  temporal 
PM2.5 quartile (Q).b
Characteristic Overall PM2.5 Q1 PM2.5 Q2 PM2.5 Q3 PM2.5 Q4
Maternal age at enrollment (years) 31.8 ± 5.2 32.0 ± 4.9 31.7 ± 5.2 32.0 ± 5.0 31.9 ± 5.4
Prepregnancy BMI (kg/m2) 24.9 ± 5.6 24.8 ± 5.9 24.7 ± 5.1 24.8 ± 5.1 24.8 ± 5.6
Pregnancy weight gain to OGTT (kg) 10.2 ± 4.4 10.4 ± 4.3 10.0 ± 4.2 10.0 ± 4.4 10.5 ± 4.9
Central-site PM2.5 (μg/m3) 10.9 ± 1.4 9.9 ± 0.7 10.7 ± 0.7 11.5 ± 0.9 12.5 ± 1.3
Spatiotemporal PM2.5 (μg/m3) 11.9 ± 1.4 10.2 ± 0.5 11.3 ± 0.3 12.3 ± 0.3 13.8 ± 0.8
Central-site black carbon (μg/m3) 0.9 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.9 ± 0.1
Spatiotemporal black carbon (μg/m3) 0.7 ± 0.2 0.6 ± 0.2 0.7 ± 0.2 0.7 ± 0.2 0.8 ± 0.2
Traffic density [(vehicles/day) × km] 1,621 ± 2,234 1,368 ± 2,201 1,692 ± 2,256 1,722 ± 2,081 1,716 ± 2,237
Roadway proximity (≤ 200 m) 281 (13) 39 (10) 55 (14) 58 (15) 60 (15)
College graduate 1,354 (65) 260 (66) 258 (65) 264 (67) 257 (65)
Race/ethnicity
White 1,397 (67) 287 (73) 265 (67) 255 (64) 253 (64)
Black 345 (17) 51 (13) 68 (17) 58 (15) 69 (17)
Asian 118 (6) 15 (4) 22 (5) 31 (8) 21 (5)
Hispanic 153 (7) 23 (6) 28 (7) 34 (9) 40 (10)
Other 80 (4) 19 (5) 13 (3) 17 (4) 12 (3)
Family history of diabetes 165 (8) 32 (8) 25 (6) 33 (8) 38 (10)
Prior history of gestational diabetes
Yes 42 (2) 10 (3) 4 (1) 7 (2) 10 (3)
No 1,052 (50) 216 (55) 204 (51) 210 (53) 180 (45)
Nulliparous 999 (48) 170 (43) 188 (47) 179 (45) 206 (52)
Glucose tolerance
GDM 118 (6) 27 (7) 15 (4) 23 (6) 21 (5)
IGT 65 (3) 9 (2) 9 (2) 12 (3) 21 (5)
Failed GCT/normal OGTT 180 (9) 29 (7) 33 (8) 44 (11) 30 (8)
Normal 1,730 (83) 331 (84) 339 (86) 317 (80) 324 (82)
aOverall sample sizes for exposures are per Table 1; for all other characteristics, imputed data are shown (n = 2,093). 
Nonimputed data are available in Supplemental Material, Table S2. bSpatiotemporal PM2.5 quartile ranges and sample 
sizes: Q1 (8.3–10.0 μg/m3; n = 396), Q2 (10.0–10.7 μg/m3; n = 396), Q3 (10.7–11.7 μg/m3; n = 396), Q4 (11.7–17.2 μg/m3; n = 396).Air pollution and glucose tolerance during pregnancy
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women living more frequently at addresses 
with lower PM2.5, and black, Hispanic, and 
Asian women at addresses with higher PM2.5 
exposure (Table 2).
In covariate-adjusted models, women 
in the highest (Q4) [vs. lowest (Q1)] quar-
tile of second-trimester PM2.5 exposure had 
1.90 times the odds (95% CI: 0.84, 4.31) 
of IGT versus normoglycemia when PM2.5 
exposure was measured at the central moni-
toring station and 2.63 times the odds (95% 
CI: 1.15, 6.01) of IGT when PM2.5 was esti-
mated by the spatiotemporal model. Odds 
of IGT versus normoglycemia for women 
in higher (Q2, Q3, Q4) versus the lowest 
(Q1) quartile of PM2.5 exposure were consis-
tently positive when PM2.5 was measured at 
the central monitoring station and increased 
monotonically across quartiles when PM2.5 
was estimated by the spatiotemporal model 
(Table 3). Results of unadjusted models were 
similar [e.g., odds of IGT for Q4 vs. Q1 
were 1.82 (95% CI: 0.83, 3.99) for central-
site PM2.5 and 2.40 (95% CI: 1.08, 5.31) for 
 spatiotemporal  PM2.5].
Women in the highest (vs. lowest) quartile 
of second-trimester black carbon exposure 
also had increased odds of IGT versus normo-
glycemia in covariate-adjusted models, but 
CIs included the null whether black carbon 
was measured at the central monitoring sta-
tion (OR = 2.87; 95% CI: 0.93, 8.83) or 
estimated by the spatiotemporal model (OR 
= 1.50; 95% CI: 0.65, 3.50). Odds of IGT 
versus normoglycemia increased monotoni-
cally across quartiles when black carbon was 
measured at the central monitoring station 
and were consistently higher in Q2, Q3, and 
Q4 versus Q1 when black carbon was esti-
mated by the spatiotemporal model (Table 3). 
In covariate-adjusted models, odds of IGT 
versus normoglycemia were also increased in 
women who lived in a neighborhood with the 
highest (vs. lowest) quartile of traffic density 
(OR = 2.66; 95% CI: 1.24, 5.71), although 
Q2, Q3, Q4 versus Q1 ORs did not increase 
monotonically, and, in fact, the Q3 versus 
Q1 comparison was close to 1. Women who 
lived ≤ 200 m (vs. > 200 m) from a major 
roadway also had increased odds of IGT vs 
normoglycemia (OR = 1.83; 95% CI: 0.96, 
3.50) (Table 3).
We found no relationship between any 
exposure and GDM in either the unadjusted 
(data not shown) or covariate-adjusted models, 
with ORs for GDM generally < 1 (Table 3). 
When we represented PM2.5, black carbon, 
and traffic density exposures as continuous 
variables (per IQR), relationships with IGT 
were consistently positive and with GDM were 
consistently null (Figure 1).
In covariate-adjusted models, odds of a 
failed GCT/normal OGTT versus normo-
glycemia were not increased for women in the 
Table 3. Covariate-adjusteda ORs (95% CIs) for failed GCT/normal OGTT, IGT, and GDM compared with 
normal glucose tolerance during pregnancy, by quartile (Q).
Exposure
Failed GCT/ 
normal OGTT IGT GDM
Central-site PM2.5 (μg/m3)
Q1 (8.3–10.0) 1.0 (Reference) 1.0 (Reference) 1.0 (Reference)
Q2 (10.0–10.7) 1.15 (0.70, 1.90) 1.43 (0.62, 3.34) 0.91 (0.50, 1.65)
Q3 (10.7–11.7) 1.05 (0.64, 1.72) 1.44 (0.63, 3.29) 0.52 (0.27, 1.00)
Q4 (11.7–17.2) 1.31 (0.80, 2.13) 1.90 (0.84, 4.31) 0.69 (0.38, 1.27)
IQR (1.7) 1.15 (0.93, 1.41) 1.34 (0.98, 1.84) 0.81 (0.62, 1.08)
Spatiotemporal PM2.5 (μg/m3)
Q1 (8.5–10.8) 1.0 (Reference) 1.0 (Reference) 1.0 (Reference)
Q2 (10.8–11.8) 1.19 (0.69, 2.03) 1.14 (0.44, 2.95) 0.62 (0.30, 1.28)
Q3 (11.8–12.8) 1.71 (1.03, 2.84) 1.46 (0.60, 3.59) 0.93 (0.48, 1.78)
Q4 (12.8–15.9) 1.11 (0.64, 1.94) 2.63 (1.15, 6.01) 0.71 (0.35, 1.42)
IQR (2.0) 1.08 (0.84, 1.40) 1.64 (1.11, 2.42) 0.94 (0.67, 1.34)
Central-site black carbon (μg/m3)
Q1 (0.60–0.78) 1.0 (Reference) 1.0 (Reference) 1.0 (Reference)
Q2 (0.78–0.87) 0.98 (0.60, 1.62) 1.16 (0.54, 2.54) 0.75 (0.39, 1.45)
Q3 (0.87–0.94) 1.53 (0.82, 2.87) 2.41 (0.87, 6.69) 0.59 (0.25, 1.35)
Q4 (0.94–1.10) 1.18 (0.58, 2.40) 2.87 (0.93, 8.83) 0.60 (0.23, 1.53)
IQR (0.16) 1.11 (0.76, 1.63) 1.36 (0.74, 2.49) 0.69 (0.42, 1.13)
Spatiotemporal black carbon (μg/m3)
Q1 (0.14–0.55) 1.0 (Reference) 1.0 (Reference) 1.0 (Reference)
Q2 (0.55–0.70) 1.03 (0.67, 1.58) 1.39 (0.66, 2.96) 1.01 (0.54, 1.87)
Q3 (0.70–0.89) 1.03 (0.65, 1.63) 1.86 (0.87, 3.98) 1.12 (0.59, 2.09)
Q4 (0.89–1.69) 1.02 (0.62, 1.68) 1.50 (0.65, 3.50) 0.90 (0.45, 1.79)
IQR (0.34) 1.01 (0.79, 1.29) 1.09 (0.74, 1.62) 1.02 (0.73, 1.41)
Neighborhood traffic densityb
Q1 (0–4,061) 1.0 (Reference) 1.0 (Reference) 1.0 (Reference)
Q2 (4,062–9,680) 1.51 (0.97, 2.36) 1.72 (0.79, 3.75) 1.18 (0.66, 2.11)
Q3 (9,680–19,371) 1.24 (0.78, 1.98) 1.04 (0.44, 2.48) 0.94 (0.51, 1.72)
Q4 (19,383–30,860) 1.38 (0.86, 2.21) 2.66 (1.24, 5.71) 0.74 (0.39, 1.42)
IQR (1,533) 1.12 (1.03, 1.23) 1.15 (1.00, 1.31) 1.02 (0.87, 1.18)
Home roadway proximity (m)
> 200 1.0 (Reference) 1.0 (Reference) 1.0 (Reference)
≤ 200 1.12 (0.69, 1.80) 1.83 (0.96, 3.51) 0.99 (0.52, 1.88)
aAdjusted for age, prepregnancy BMI, pregnancy weight gain, education, race/ethnicity, family history of diabetes, prior 
GDM, and season of last menstrual period. bVehicles/day × km road within 100 m.
Figure 1. Associations of second-trimester exposure to PM2.5, second-trimester exposure to black carbon, 
neighborhood traffic density based on enrollment address, and home roadway proximity based on enroll-
ment address, with risk for IGT and GDM during pregnancy. Data were from 2,093 Boston-area pregnant 
women in Project Viva. IQR, interquartile range. IQR = 0.16 μg/m3 for central-site black carbon, 0.34 μg/m3 
for spatiotemporal black carbon, 1.7 μg/m3 for central-site PM2.5, 2.0 μg/m3 for spatiotemporal PM2.5, 1,533 
vehicles/day × km for neighborhood traffic density.
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highest (vs. lowest) quartile of spatiotemporal 
PM2.5 (OR = 1.11; 95% CI: 0.64, 1.94) or 
other exposures (Table 3). When we included 
a variable for time trend or prepregnancy 
BMI squared to the final model, results were 
unchanged (data not shown). Inclusion of 
census tract median income slightly attenu-
ated effect estimates for associations of IGT 
with spatiotemporal black carbon (OR for 
Q4 vs. Q1 = 1.24; 95% CI: 0.51, 3.05), 
spatio temporal  PM2.5 (2.4; 95% CI: 1.04, 
5.53), and traffic density (2.41; 95% CI: 
1.11, 5.25) but not for any other exposure–
outcome relationships. When we restricted the 
analyses to women without prior GDM or to 
women with a measured rather than imputed 
outcome, results were also unchanged (data 
not shown). When we included both spatio-
temporal PM2.5 and traffic density in the same 
adjusted model, odds of failed GCT/normal 
OGTT, IGT, or GDM versus normoglycemia 
per IQR increase in exposure were essentially 
unchanged. For example, an IQR increase 
in spatiotemporal PM2.5 exposure increased 
odds of IGT by 1.60 (95% CI: 1.08, 2.37) 
(vs. single-pollutant model OR = 1.64; 95% 
CI: 1.11, 2.42), and an IQR increase in traffic 
density increased odds of IGT by 1.17 (95% 
CI: 1.01, 1.35) (vs. single-pollutant model 
OR = 1.15; 95% CI: 1.0, 1.31).
Discussion
Among pregnant women residing in the 
greater Boston area, second-trimester PM2.5 
exposure was positively associated with IGT, 
but not frank GDM. Second-trimester black 
carbon exposure, and traffic density and road-
way proximity based on enrollment address 
also appeared to be associated with IGT.
Our results are consistent with previ-
ous studies suggesting glycemic effects of air 
pollution. Long-term exposure to PM2.5 and 
PM10 (PM with diameter < 10 μm) and self-
reported type 2 diabetes mellitus has been 
studied in several adult cohorts (Andersen 
et al. 2012; Brook et al. 2008; Coogan et al. 
2012; Krämer et al. 2010; Pearson et al. 2010; 
Puett et al. 2011), of which all but one (Puett 
et al. 2011) reported positive associations 
between diabetes and particulate matter expo-
sures. Studies of short-term PM2.5 and PM10 
exposure in adults have also demon  strated an 
association between exposure during the days 
before a blood draw and biochemical measures 
of insulin resistance (Brook et al. 2013; Kim 
and Hong 2012).
Two prior studies have considered air pol-
lution exposure and glycemia in pregnancy, 
and results were conflicting. A cohort study of 
> 7,000 pregnant women in the Netherlands 
(van den Hooven et al. 2009) found no asso-
ciation between traffic density and GDM. 
In contrast, a study of birth registry data for 
> 81,000 births in Sweden (Malmqvist et al. 
2013) reported monotonic dose–response 
associations between NOx and GDM, and 
positive associations with traffic density.
In rodent models, PM2.5 exposure 
resulted in greater oxidative stress and adipose 
tissue inflammation [reviewed by Anderson 
et al. (2012); Franchini et al. (2012)]. 
Adipose inflammatory changes included 
increased proinflammatory to antiinflamma-
tory macrophage ratio and insulin signaling 
abnormalities, which could lead to insulin 
resistance (Sun et al. 2009; Xu et al. 2011). 
Obesity-induced insulin resistance is thought 
to similarly occur as a direct result of adipose 
inflammation (Ye 2013).
It is uncertain whether the traffic com-
ponents of PM (e.g., black carbon) are 
responsible for these associations. Traffic 
and nontraffic PM components have been 
associated with increases in systemic inflam-
matory markers and with adverse vascular 
responses in adults with diabetes (Gold 2008; 
O’Neill et al. 2005). In the present study, 
an IQR increase in PM2.5 exposure (esti-
mated in spatiotemporal models) was more 
strongly associated with IGT than an IQR 
increase in traffic density when both variables 
were included in the same adjusted model. 
Although this difference could reflect differ-
ent degrees of measurement error in the expo-
sure variables, it may also suggest a greater 
impact of nontraffic PM versus traffic-related 
PM on IGT. Traffic density captures spatial 
variability from locally generated air pollution 
but lacks temporal resolution; therefore, it 
may have been less strongly related to IGT 
because of inadequate capture of regional par-
ticle movement occurring specifically during a 
woman’s second trimester of pregnancy.
Although there was an association of air 
pollution exposure with IGT, contrary to our 
hypothesis, we did not demonstrate an associ-
ation with frank gestational diabetes. In fact, 
ORs for GDM were generally < 1, although 
CIs all included the null. This result is con-
sistent with several studies that have reported 
gestational weight gain, another modifiable 
exposure during gestation, to be associated 
with IGT but not GDM (Herring et al. 
2009; Saldana et al. 2006; Tovar et al. 2009). 
Mothers predisposed to eventually develop 
GDM may enter pregnancy with an array of 
preexisting risk factors such as greater pre-
gravid weight and family history of diabetes 
(Solomon et al. 1997) and may develop 
GDM regardless of additional behavioral or 
environmental risk factors during pregnancy. 
Thus, more severe degrees of hyperglycemia 
may be less sensitive to short-term exposures. 
Another possible explanation for the differen-
tial results for IGT versus GDM is that indi-
viduals with undiagnosed, preexisting diabetes 
may have been included in the GDM group, 
thus limiting our ability to demonstrate an 
association with pregnancy-specific exposures. 
In any case, it will be necessary to replicate 
this finding in future work, because prior 
studies of air pollution and glucose toler-
ance in pregnancy (Malmqvist et al. 2013; 
van den Hooven et al. 2009) did not include 
a separate IGT designation.
Even mild degrees of abnormal glycemia 
in pregnancy (i.e., IGT) have been associ-
ated with adverse perinatal clinical outcomes 
(Hapo Study Cooperative Research Group 
et al. 2008; Sermer et al. 1995) and future 
obesity and insulin resistance in both mother 
and offspring (Hillier et al. 2007). To put 
our findings into perspective, the extent to 
which second-trimester spatiotemporal PM2.5 
exposure increased odds of IGT in the present 
study (OR = 2.63; 95% CI: 1.15, 6.01, for 
highest vs. lowest quartile of exposure) is of 
the same order of magnitude as that of other 
well-known risk factors for IGT. For example, 
in our cohort, the OR of IGT was 2.54 (95% 
CI: 1.25, 5.15) for women in the highest 
versus lowest quartile of gestational weight 
gain, and was 1.89 (95% CI: 1.04, 3.44) for 
those with pregravid overweight versus normal 
weight (Herring et al. 2009).
Potential exposure misclassification is a 
limitation of the present study. The PM2.5 
spatiotemporal model we used had a high 
mean out-of-sample R2, and use of satellite 
aerosol optical depth data was a strength, but 
air pollution estimates (for both PM2.5 and 
black carbon models) were based on residen-
tial address, and we did not have informa-
tion on work location or time spent at home 
which could have improved the accuracy of 
exposure estimates (Nethery et al. 2008). Also, 
the PM2.5 spatiotemporal model estimated 
10 × 10 km exposures, which could limit local 
contrast. However, the 2,093 women lived 
in 110 different 10 × 10 km cells through-
out eastern Massachusetts, so there was still 
broad exposure variability. Also, the number 
of women with PM2.5 spatiotemporal esti-
mates based on satellite data, which was not 
available before March 2000, was limited. 
Compared with those with available estimates, 
women missing spatiotemporal PM2.5 esti-
mates had differences in their exposure profile, 
likely as a result of changing exposures over 
time. However, exposure differences would 
not be expected to bias results, as these women 
did not differ in terms of sociodemographic 
characteristics or proportion of IGT or GDM. 
Because the women were pregnant from 1999 
through 2002, our use of 2009 traffic den-
sity in the black carbon spatiotemporal model 
may have increased exposure misclassification. 
Another limitation is use of self-reported 
prepregnancy weight, which may be under-
estimated, but a prior validation study of 170 
Project Viva participants with measured pre-
pregnancy weight suggested that ranking of Air pollution and glucose tolerance during pregnancy
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individuals is preserved, and weight reporting 
did not differ by BMI or race/ethnicity (Oken 
et al. 2007). Also, generalizability may be lim-
ited because our cohort was older and mostly 
white, although the proportions of racial/
ethnic minorities in Project Viva were higher 
than in Massachusetts as a whole, according to 
the 2000 census (U.S. Census Bureau 2000b). 
Strengths of our study include use of a large, 
prospective cohort with several measures of air 
pollution exposure and inclusion of multiple 
potential confounding variables. However, we 
did not account for every factor that might be 
related to pollution exposure and GDM risk, 
such as physical activity.
Conclusions
In summary, second-trimester PM2.5 exposure 
was associated with impaired glucose toler-
ance, but not GDM, among pregnant women. 
Our results lend support to the emerging 
body of evidence that air pollution exposure is 
  associated with abnormal glycemia.
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